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Graphical abstract
Diphtheria AB toxin mode of action. The diphtheria AB exotoxin consists of two polypeptide chains – A and B which are linked
by a disulfide bridge. The B chain binds to the heparin-binding epidermal growth factor precursor on eukaryotic cells and is
endocytosed. Acidification of the endosome results in a conformational change to the A and B chains and breaking of
the disulphide bridge. The B chain remains in the endosome, but the A chain is translocated to the cytoplasm where it
ADP-ribosylates host eEF-2, blocking protein synthesis which leads to cell death.
Abstract
Corynebacterium diphtheriae is a globally important Gram-positive aerobic Actinobacterium capable of causing the toxin-
mediated disease, diphtheria. Diphtheria was a major cause of childhood mortality prior to the introduction of the toxoid
vaccine, yet it is capable of rapid resurgence following the breakdown of healthcare provision, vaccination or displacement of
people. The mechanism and treatment of toxin-mediated disease is well understood, however there are key gaps in our
knowledge on the basic biology of C. diphtheriae particularly relating to host colonisation, the nature of asymptomatic
carriage, population genomics and host adaptation.
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TAXONOMY
Domain Bacteria, phylum Actinobacteria, order Corynebac-
teriales, family Corynebacteriaceae, genus Corynebacterium,
species C. diphtheriae. It is often further divided into four
biovars (belfanti, intermedius, gravis, mitis) based on bio-
chemical testing, however this is not well supported by
genomic analysis [1].
PROPERTIES
C. diphtheriae is a Gram-positive, aerobic, non-sporulating,
non-capsulated and non-motile bacterium of around 2 µm
in length. C. diphtheriae is the aetiological agent of the
upper respiratory disease diphtheria and is generally consid-
ered an archetypal upper respiratory mucosal pathogen,
however in recent years it has become apparent that inva-
sive strains exist [2]. Diphtheria is a toxin-mediated disease,
caused by strains lysogenized by the temperate b-coryne-
phage which carry the iron-regulated diphtheria-toxin gene
[3]. C. diphtheriae possesses a complex cell envelope archi-
tecture consisting of peptidoglycan linked to a layer arabi-
nogalactan decorated with mycolic acids and glycolipids [4].
GENOME
The genome of C. diphtheriae is around 2.45 Mbp, with a
core genome of around 1632 genes and a pan-genome of
around 4786 genes [5]. The genome has a G+C content of
approximately 53.5% with a coding density of around 88%
[6]. The differences between genomes is largely confined to
the presence of prophages, transposons, restriction-modifi-
cation systems and CRISPR elements. A total of 57 genomic
islands have been identified and it appears that recombina-
tion plays an important role in C. diphtheriae genome evo-
lution [2]. There is some variation in the genomes that
relate to pathogenicity, with b-corynephage carriage being
variable between strains and its presence does not correlate
with MLST or biovar designations. Additionally, non-toxi-
genic, tox gene-bearing strains are also found as clinical iso-
lates. Variation is also observed in the pilli encoding spa
operons, with at least two operons being present in all
strains, but with varying numbers of pilus subunit encoding
genes being found within genomes. This variation in pilus
structure correlates well with the ability of C. diphtheriae
strains to cause severe, invasive non-toxigenic disease [5, 7].
PHYLOGENY
The genus Corynebacterium forms a monophyletic family
within the order Corynebacteriales [8]. The phylogenetic
relationships within this group are complex and only the
closely related zoonotic pathogens C. pseudotuberculosis
and C. ulcerans are capable of causing diphtheria-toxin-
mediated disease along with C. diphtheriae [9]. This sug-
gests that C. diphtheriae strains may have initially emerged
as a pathogen in animals prior to human host adaptation.
KEY FEATURES AND DISCOVERIES
Toxigenic C. diphtheriae is responsible for causing severe,
inflammatory, toxin-mediated upper respiratory tract dis-
ease characterized by the presence of a grey layer of dead tis-
sue termed the pseudomembrane. Initial symptoms are
characterized by severe sore throats, high temperature and
can often lead to death. The diphtheria AB exotoxin binds
to host heparin-binding epidermal growth factor precursor.
The toxin is subsequently endocytosed and processed within
the cell, resulting in the ribosylation of eEF-2 causing inhibi-
tion of protein synthesis leading to cell death (see Graphical
abstract). In addition to toxin-mediated disease, significant
human disease can be caused by non-toxigenic C. diphther-
iae strains, which are now emerging as a significant cause of
infections such as persistent sore throats, endocarditis, sep-
tic arthritis, osteomyelitis and cutaneous infections [2].
C. diphtheriae was first isolated by Loeffler [10] and was one
of the first applications of ‘Koch’s Postulates’ to confirm the
aetiological agent of a disease. Prior to the introduction of
the vaccine in industrialized countries in the 1940s and
1950s, diphtheria was a leading cause of child mortality.
Diphtheria remains a significant health problem in coun-
tries with poor routine vaccine coverage and under-report-
ing of cases in certain areas suggests the burden of disease is
likely to be greater than reported. The introduction of the
vaccine and the subsequent global immunization initiative
reduced cases to around 5000 per year globally. Major post-
vaccination epidemics have included those in the 1990s in
the former Soviet Union states (>157 000 cases and around
5000 deaths), notable outbreaks in Colombia, India, Nor-
way, Nigeria, Thailand, Brazil, Laos [2] and most recently in
2017 in Indonesia, Venezuela and Bangladesh. The majority
of these outbreaks can be linked to the collapse of healthcare
provision due to social upheaval or the displacement of
people due to armed conflict, famine, natural disasters and
economic changes. This emphasizes the efficacy and impor-
tance of vaccination programmes, prior to and during out-
breaks, and highlights that diphtheria can rapidly re-emerge
given the right conditions with devastating effects.
The diphtheria vaccine is a toxoid composed of formaldehyde
inactivated diphtheria exotoxin. The vaccine is normally deliv-
ered in combination with tetanus and acellular pertussis to
children under 7 years of age, although in the UK (as of
August 2017) it is now delivered as part of the 6 in 1 vaccine
given at 8, 12 and 16weeks. Treatment of diphtheria is nor-
mally with antitoxin, to neutralize the effects of circulating
exotoxin along with a course of antibiotics (usually penicillin
or erythromycin). Non-toxigenic C. diphtheriae infections
usually respond to penicillin or erythromycin treatment, with
antibiotic resistance not commonly observed in C. diphtheriae
strains.
KEY QUESTIONS
. We have little understanding of asymptomatic carriage
of non-toxigenic C. diphtheriae strains as part of the
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natural upper respiratory tract microbial community,
yet there is potential for these strains to undergo phage
conversion (to produce toxin) followed by dissemina-
tion resulting in disease outbreaks. Is this a major driver
in the rapid resurgence of diphtheria in unvaccinated
and/or displaced populations?
. What factors govern the colonization, persistence and
invasive nature of C. diphtheriae in the naso-pharynx
beyond the few relatively well-known virulence factors?
. Does vaccine-driven selection play a role in the emer-
gence of non-toxigenic invasive C. diphtheriae strains?
. Vaccinated individuals produce antibodies to neutralize
the effects of the exotoxin but it is unclear if this is suf-
ficient to prevent colonization or eliminate non-toxi-
genic strains from the host.
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